Inceptua welcomes Vesey Street Capital Partners as majority shareholder
Inceptua continues to go from strength to strength and has now reached a major milestone on its journey of growth. We are delighted to share the news that Vesey Street Capital Partners, LLC (“VSCP”) – a US-based private equity firm focused on the healthcare service sector – has agreed to join us as investor and majority shareholder.
Over the past few years Inceptua has successfully strengthened its position as a leading, dedicated service partner to Pharma and Biotech companies providing clinical trial supply, clinical services, and early access worldwide.
Peter Krantz, founder of Inceptua, said: “The partnership with VSCP will help Inceptua’s strategy of expanding its capabilities within its core business to develop additional and complementary services in-line with our customers’ global needs.”
Stefan Fraenkel, CEO of Inceptua, said “I am excited to be working with the VSCP team, given their experience and expertise in the pharmaceutical services industry, as we continue our successful growth journey. This partnership is a tremendous opportunity to enhance and expand our services to customers around the world.”
As a part of the change in ownership, we are pleased to announce that Doug Cook, formerly EVP and President of Global Commercialization Services and Animal Health at Cencora, Inc. (formerly AmerisourceBergen Corporation), will be joining Inceptua as Executive Chairman and working in partnership with VSCP, Inceptua CEO Stefan Fraenkel, and the rest of the Inceptua team.
“Vesey Street Capital Partners is both excited and honored to be working with Doug, Stefan and the entire Inceptua team to enhance the value proposition and support future growth initiatives,” said Adam Feinstein, Managing Partner at VSCP.
Larry Marsh, Investment Partner at VSCP, added “Having had a long-standing relationship with Doug Cook, we are extremely enthused about working with Doug and Stefan to bring more value to our customers globally as they seek to drive innovation.”